The German healthcare system was among the first markets to introduce transcatheter mitral valve repair (TMVR) in routine care for patients suffering from mitral valve insufficiency. Our objective was to estimate the impact of TMVR availability on overall mitral valve repair volumes and competing therapies in this real-world setting.
